Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies. - Wikidata - wikimedia - TriplyDB

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

http://www.wikidata.org/entity/Q42226048

about

Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients.The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis.TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations When uncommon and common coalesce: adult onset Still's disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA).Acute adult-onset still's disease presenting as pulmonary hemorrhage, urticaria, angioedema and leukemoid reaction: a case report and literature review Treatment of adult-onset still's disease: up to date.Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.Adult-Onset Still's Disease Masquerading as Sepsis in an Asplenic Active Duty Soldier.Elevated serum levels of free interleukin-18 in adult-onset Still's disease.Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

P2860

Q33414045-DBDED0EB-DD54-4DCF-9AC4-64687B9821FC Q34966670-6C702802-92C7-4BBD-84B2-0B68728CD596 Q36073815-8A5AB284-1EDB-4FB5-A549-0915F1F350A6 Q36231477-DD12E4B8-E280-4EC1-8AC6-8515E813D075 Q37210206-6987CBF1-9D83-4760-A0A9-204FCC884FA3 Q38325562-A12F0325-2ABF-40E4-9E0F-00BF85A65172 Q38482499-090629CF-4AC1-4365-940B-714A5EE220D1 Q38679486-98E27306-09D6-4093-A30D-B56A184F318C Q40235629-EA9371E4-AFC0-46D1-B464-60ACFC52877C Q40263935-13F7CDC5-80AC-43EE-8E86-7A27D92CC020 Q51520537-8D3F7DE2-2661-44B7-AB44-6862DFD8658F Q51748695-9388DBF4-BE93-4A8F-8CD0-44BF288E2A81 Q52642372-871ADF18-1D72-4141-9404-C04D7DFB7A6E Q52675492-B0A78D17-9CF3-42E7-8D28-65D028BD7A91

P2860

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

http://www.wikidata.org/entity/Q42226048

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

@en

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

@nl

type

label

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

@en

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

@nl

prefLabel

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

@en

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

@nl

P1433

Q42226048-D4DE618F-0570-49BF-B1D5-0489A47F5698

P1476

Q42226048-079AF7E0-169F-4180-9592-29110A7BC0A0

P2093

Q42226048-48850D61-0F85-47C7-88FC-1993449CA4D3

Q42226048-499AB133-BC62-4372-9C0B-6D067FE7BE0B

Q42226048-909DAFA5-F1F3-464B-8C24-8133391D4A58

P2860

Q42226048-015A57C0-25F2-4172-A917-513C66AB936F

Q42226048-0DD83CC7-DA13-49D9-A256-529897BEAC8D

Q42226048-11D86903-9221-453B-8A85-BEBF13B11D2B

Q42226048-11FBEE02-ACB1-468C-AB6B-1ECE9B0A78AD

Q42226048-12924849-8C16-482E-A29A-BD5086FD71A0

Q42226048-12DDF276-DF3D-41B1-A6FA-7E9DE14F42F2

Q42226048-13065063-E4C3-48C9-98E0-30CE6E96E116

Q42226048-15D692F2-3120-40D3-B811-867834A3B4BF

Q42226048-163ECBCC-E254-41D2-9400-BD5FB519679F

Q42226048-1B64B46C-FBAF-4CD8-9822-9D3915FE4055

P304

Q42226048-01958690-3FE5-48BC-AC54-0CD6F2860C8A

P31

Q42226048-4143FAF5-5BAD-4139-A122-C72048B694E8

P356

Q42226048-95D88C19-9739-4186-89CE-747723E83769

P478

Q42226048-FA314978-5D4F-4FD0-890B-B61B4C734517

P577

Q42226048-69A0E1DB-1C3E-491C-B64E-69307DF9FC1A

P5875

Q42226048-62A48A30-BBBD-4C0D-8C14-2E9B76076A62

P698

Q42226048-D15F11D1-0150-41C1-ACB2-42436F386157

P921

Q42226048-68D8143E-19A8-4E18-9CF6-96FF576709E2

P932

Q42226048-EE01615B-64D2-471D-BA6C-76F570E82668

P356

P1433

International Journal of Inflammation

P1476

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

@en

P2093

Clio P Mavragani

http://www.w3.org/2001/XMLSchema#string

Evangelos G Spyridakis

http://www.w3.org/2001/XMLSchema#string

Michael Koutsilieris

http://www.w3.org/2001/XMLSchema#string

P2860

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolong

Primer: inflammasomes and interleukin 1beta in inflammatory disorders

Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea

Low dose methotrexate treatment in adult Still's disease

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab.

Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease.

Association between adult-onset Still's disease and interleukin-18 gene polymorphisms.

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.

P304

879020

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/879020

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229083496

http://www.w3.org/2001/XMLSchema#string

P698

22792508

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

3390042

http://www.w3.org/2001/XMLSchema#string